Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

By Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 904-914

Elsevier

Access to resources Recommend Favorite

Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease

By Gipson C.L.   Davis N.L.   Johnston R.E.   de Silva A.M.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3875-3884

Elsevier

Access to resources Recommend Favorite

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey

By Philipp M.T.   Lobet Y.   Bohm R.P.   Roberts E.D.   Dennis V.A.   Gu Y.   Lowrie R.C.   Desmons P.   Duray P.H.   England J.D.   Hauser P.   Piesman J.   Xu K.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1872-1887

Elsevier

Access to resources Recommend Favorite

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite

Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

By Chang Y.-F.   Novosol V.   McDonough S.P.   Chang C.-F.   Jacobson R.H.   Divers T.   Quimby F.W.   Shin S.   Lein D.H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 540-548

Elsevier

Access to resources Recommend Favorite